BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33197899)

  • 1. Silver nanoparticles functionalized Paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells.
    Muhammad N; Zhao H; Song W; Gu M; Li Q; Liu Y; Li C; Wang J; Zhan H
    Nanotechnology; 2021 Feb; 32(8):085105. PubMed ID: 33197899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Gold Nanoparticles and Paclitaxel Co-Delivery System for Enhanced Anti-Cancer Effect Through Chemo-Photothermal Combination.
    Zhan H; Song W; Gu M; Zhao H; Liu Y; Liu B; Wang J
    J Biomed Nanotechnol; 2022 Apr; 18(4):957-975. PubMed ID: 35854456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
    Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
    Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold Nanoparticle-Decorated Drug Nanocrystals for Enhancing Anticancer Efficacy and Reversing Drug Resistance Through Chemo-/Photothermal Therapy.
    Wang J; Zhao H; Song W; Gu M; Liu Y; Liu B; Zhan H
    Mol Pharm; 2022 Jul; 19(7):2518-2534. PubMed ID: 35549267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
    Yang X; Cai X; Yu A; Xi Y; Zhai G
    J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals.
    Wang J; Lv FM; Wang DL; Du JL; Guo HY; Chen HN; Zhao SJ; Liu ZP; Liu Y
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32019194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability.
    Huang ZG; Lv FM; Wang J; Cao SJ; Liu ZP; Liu Y; Lu WY
    Int J Pharm; 2019 Feb; 556():217-225. PubMed ID: 30557679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
    Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
    Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of Silver Nanoparticles Loaded with Paclitaxel-induced A549 Cells Apoptosis Through ROS-Mediated Signaling Pathways.
    Zou J; Zhu B; Li Y
    Curr Top Med Chem; 2020; 20(2):89-98. PubMed ID: 31648639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
    Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
    Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.
    Xiong W; Peng L; Chen H; Li Q
    Int J Nanomedicine; 2015; 10():2985-96. PubMed ID: 25945046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells.
    Niu S; Bremner DH; Wu J; Wu J; Wang H; Li H; Qian Q; Zheng H; Zhu L
    Drug Deliv; 2018 Nov; 25(1):1275-1288. PubMed ID: 29847177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
    Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
    J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new targeted delivery approach by functionalizing drug nanocrystals through polydopamine coating.
    Zhan H; Jagtiani T; Liang JF
    Eur J Pharm Biopharm; 2017 May; 114():221-229. PubMed ID: 28161549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herceptin-functionalized pure paclitaxel nanocrystals for enhanced delivery to HER2-postive breast cancer cells.
    Noh JK; Naeem M; Cao J; Lee EH; Kim MS; Jung Y; Yoo JW
    Int J Pharm; 2016 Nov; 513(1-2):543-553. PubMed ID: 27686050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.